BDR Pharmaceuticals International Private Limited — Sunitinib Exporter Profile
Indian Pharmaceutical Exporter · #8 for Sunitinib · $198.2K export value · DGFT Verified
BDR Pharmaceuticals International Private Limited is the #8 Indian exporter of Sunitinib with $198.2K in export value and 17 verified shipments. BDR Pharmaceuticals International Private Limited holds a 0.3% market share in Sunitinib exports across 2 countries. The company exports 12 pharmaceutical products worth $4.4M across 3 therapeutic categories.
BDR Pharmaceuticals International Private Limited — Sunitinib Export Profile: Buyers & Destinations
Where Does BDR Pharmaceuticals International Private Limited Export Sunitinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PERU | $159.9K | 16 | 99.3% |
| UGANDA | $1.1K | 1 | 0.7% |
BDR Pharmaceuticals International Private Limited exports Sunitinib to 2 countries. The largest destination is PERU accounting for 99.3% of BDR Pharmaceuticals International Private Limited's Sunitinib shipments. These destinations reflect BDR Pharmaceuticals International Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sunitinib from BDR Pharmaceuticals International Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DIDRSASR | PERU | $120.3K | 12 |
| DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL | PERU | $39.6K | 4 |
| ONLT | UGANDA | $1.1K | 1 |
BDR Pharmaceuticals International Private Limited supplies Sunitinib to 3 buyers globally. The largest buyer is DIDRSASR (PERU), followed by DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL (PERU) and ONLT (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sunitinib Export Value and How Much Does BDR Pharmaceuticals International Private Limited Contribute?
India exported $9.9M worth of Sunitinib through 607 shipments from 114 suppliers to 76 countries, serving 188 buyers globally. BDR Pharmaceuticals International Private Limited contributes $198.2K to this total, accounting for 0.3% of India's Sunitinib exports. BDR Pharmaceuticals International Private Limited ships Sunitinib to 2 countries through 3 buyers.
What Is the Average Shipment Value for BDR Pharmaceuticals International Private Limited's Sunitinib Exports?
BDR Pharmaceuticals International Private Limited's average Sunitinib shipment value is $11.7K per consignment, based on 17 shipments totaling $198.2K. The largest destination is PERU (99.3% of BDR Pharmaceuticals International Private Limited's Sunitinib exports).
How Does BDR Pharmaceuticals International Private Limited Compare to Other Indian Sunitinib Exporters?
BDR Pharmaceuticals International Private Limited ranks #8 among 114 Indian Sunitinib exporters with a 0.3% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.9M), MSN LABORATORIES PRIVATE LIMITED ($1.0M), SUN PHARMACEUTICAL INDUSTRIES LTD ($450.0K). BDR Pharmaceuticals International Private Limited processed 17 shipments to 2 destination countries.
What Sunitinib Formulations Does BDR Pharmaceuticals International Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SUNITINIB 25MG (DOXETIN) (TAX INVMH1160 | $50.0K | 1 |
| SUNITINIB 25MG DOXETIN TAX INVMH1160000341 DT23.10.2023 | $39.6K | 1 |
| SUNITINIB 25MG (DOXETIN) (OTHER)(TAX INV# MH1160000634 DT:21.03.2024) | $28.0K | 1 |
| SUNITINIB 25 MG (DOXETIN) (OTHER) (TAX INV# MH2411600061 DT: 13.05.2024) | $23.7K | 1 |
| SUNITINIB 25MG DOXETIN TAX INVMH1160 | $18.6K | 1 |
| SUNITINIB 25MG CAPSULE (RCNET 25MG) (TAX INV# MH2411600551 DT: 13.02.2025) | $1.1K | 1 |
| SUNITINIB MESYLATE PLACEBO FOC | $0 | 1 |
| SUNITINIB MESYLATE WS FOC | $0 | 1 |
| SUNITINIB 25 MG DOXETIN SAMPLE 60 BOX | $0 | 1 |
| SUNITINIB WS 500 MG +1 GR PLACEBO (FOC) | $0 | 1 |
BDR Pharmaceuticals International Private Limited exports 17 distinct Sunitinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SUNITINIB 25MG (DOXETIN) (TAX INVMH1160 with 1 shipments worth $50.0K.
How Does BDR Pharmaceuticals International Private Limited Compare to Nearest Sunitinib Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $204.8K | 6 | 2 | $34.1K |
| 2 | DR REDDYS LABORATORIES LIMITED | $200.0K | 4 | 2 | $50.0K |
| 8 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ★ | $198.2K | 17 | 2 | $11.7K |
| 9 | TEYRO LABS PRIVATE LIMITED | $89.5K | 6 | 2 | $14.9K |
| 10 | EUGIA PHARMA SPECIALITIES LIMITED | $59.8K | 3 | 1 | $19.9K |
BDR Pharmaceuticals International Private Limited ranks #8 among 114 Indian Sunitinib exporters. Average shipment value of $11.7K compared to the market average of $87.1K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and DR REDDYS LABORATORIES LIMITED.
Which Indian Ports Ship Sunitinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 177 | 29.2% |
| SAHAR AIR | 118 | 19.4% |
| DELHI AIR | 40 | 6.6% |
| DELHI AIR CARGO ACC (INDEL4) | 38 | 6.3% |
| Bombay Air Cargo | 25 | 4.1% |
| HYDERABAD ACC (INHYD4) | 22 | 3.6% |
| HYDERABAD AIR | 16 | 2.6% |
| NHAVA SHEVA SEA (INNSA1) | 15 | 2.5% |
What Other Advanced Oncology Products Does BDR Pharmaceuticals International Private Limited Export?
BDR Pharmaceuticals International Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About BDR Pharmaceuticals International Private Limited
BDR Pharmaceuticals International Private Limited exports 12 products worth $4.4M. Beyond Sunitinib, top products include Tamoxifen, Everolimus, Lapatinib, Capecitabine, Thalidomide. View the complete BDR Pharmaceuticals International Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sunitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sunitinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: BDR Pharmaceuticals International Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 17 individual customs records matching BDR Pharmaceuticals International Private Limited exporting Sunitinib, covering 17 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 76+ countries, 188+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sunitinib Export Data from BDR Pharmaceuticals International Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for BDR Pharmaceuticals International Private Limited's Sunitinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BDR Pharmaceuticals International Private Limited
Full Company Profile →
12 products · $4.4M total trade · 3 categories
Sunitinib Stats
Company Overview
Top Products by BDR Pharmaceuticals International Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for BDR Pharmaceuticals International Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sunitinib. For current shipment-level data, contact TransData Nexus.